Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-49179
Gnädinger, M; Mellinghoff, H U; Kaelin-Lang, A (2011). Parkinson's disease and the bones. Swiss Medical Weekly, 141:w13154.
View at publisher
Any newly diagnosed patient with PD should be evaluated for the risk of falling and osteoporosis and routinely be supplemented with vitamin D. In the case of osteoporosis, blood samples for detecting underlying and treatable conditions should be taken and bisphosphonates administered to the patient. It is unclear whether drugs typically used for PD provoke or worsen osteoporosis. Nevertheless, every long-term medication should undergo safety studies to demonstrate lack of negative interference with bone metabolism. Drug admission authorities should demand these data when registering new substances or when renewing old admissions.
174 downloads since deposited on 22 Aug 2011
39 downloads since 12 months
|Item Type:||Journal Article, refereed, original work|
|Communities & Collections:||04 Faculty of Medicine > University Hospital Zurich > Institute of General Practice|
|Dewey Decimal Classification:||610 Medicine & health|
|Deposited On:||22 Aug 2011 08:46|
|Last Modified:||05 Apr 2016 14:58|
|Publisher:||EMH Swiss Medical Publishers|
Users (please log in): suggest update or correction for this item
Repository Staff Only: item control page